US20030186963A1 - Substituted piperidines - Google Patents
Substituted piperidines Download PDFInfo
- Publication number
- US20030186963A1 US20030186963A1 US10/245,236 US24523602A US2003186963A1 US 20030186963 A1 US20030186963 A1 US 20030186963A1 US 24523602 A US24523602 A US 24523602A US 2003186963 A1 US2003186963 A1 US 2003186963A1
- Authority
- US
- United States
- Prior art keywords
- alkyl
- cycloalkyl
- aryl
- substituted
- alkanoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 [1*]N1CCC(N([2*])C(=O)*[Y])CC1.[3*]C.[4*]C Chemical compound [1*]N1CCC(N([2*])C(=O)*[Y])CC1.[3*]C.[4*]C 0.000 description 5
- DFAUJUCCRZPTIV-VMPITWQZSA-N CCOC1=CC=C(Br)C=C1/C=C/C(=O)N(C)C1CCN(C)CC1 Chemical compound CCOC1=CC=C(Br)C=C1/C=C/C(=O)N(C)C1CCN(C)CC1 DFAUJUCCRZPTIV-VMPITWQZSA-N 0.000 description 2
- IZKFBPRVXJEYBB-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CCC2=CC=C(C(F)(F)F)C=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CCC2=CC=C(C(F)(F)F)C=C2)CC1 IZKFBPRVXJEYBB-UHFFFAOYSA-N 0.000 description 2
- ZFBDYMVAKOUBHI-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CSCC2=C3C=CC=CC3=CC=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CSCC2=C3C=CC=CC3=CC=C2)CC1 ZFBDYMVAKOUBHI-UHFFFAOYSA-N 0.000 description 2
- DLALROLWSFEYGD-UHFFFAOYSA-N COC1=C(OCC(=O)N(C)C2CCN(C)CC2)C=CC=C1 Chemical compound COC1=C(OCC(=O)N(C)C2CCN(C)CC2)C=CC=C1 DLALROLWSFEYGD-UHFFFAOYSA-N 0.000 description 2
- PWTYVNFOSUSIQV-UHFFFAOYSA-N COC1=CC=C(OCC(=O)N(C)C2CCN(C)CC2)C=C1 Chemical compound COC1=CC=C(OCC(=O)N(C)C2CCN(C)CC2)C=C1 PWTYVNFOSUSIQV-UHFFFAOYSA-N 0.000 description 2
- NNXKFDVZUSGZGK-UHFFFAOYSA-N C/C1=C(\CC(=O)N(C)C2CCN(C)CC2)SC2=C1C=C(Cl)C=C2 Chemical compound C/C1=C(\CC(=O)N(C)C2CCN(C)CC2)SC2=C1C=C(Cl)C=C2 NNXKFDVZUSGZGK-UHFFFAOYSA-N 0.000 description 1
- PKNLSZYSDGCJCO-UHFFFAOYSA-N CC(=O)C1=C(OCC(=O)N(C)C2CCN(C)CC2)C=CC=C1 Chemical compound CC(=O)C1=C(OCC(=O)N(C)C2CCN(C)CC2)C=CC=C1 PKNLSZYSDGCJCO-UHFFFAOYSA-N 0.000 description 1
- YOZOJRLZHXWBLZ-UHFFFAOYSA-N CC(=O)C1=CC=C(OCC(=O)N(C)C2CCN(C)CC2)C=C1 Chemical compound CC(=O)C1=CC=C(OCC(=O)N(C)C2CCN(C)CC2)C=C1 YOZOJRLZHXWBLZ-UHFFFAOYSA-N 0.000 description 1
- VWNJHHLCNMFGAF-UHFFFAOYSA-N CC(C)(C)CCC1=CC=CC=C1.CC(C)(C)OCC1=CC=CC=C1.CC(C)CC1=CC=CC=C1 Chemical compound CC(C)(C)CCC1=CC=CC=C1.CC(C)(C)OCC1=CC=CC=C1.CC(C)CC1=CC=CC=C1 VWNJHHLCNMFGAF-UHFFFAOYSA-N 0.000 description 1
- YCTOJFKTSGRHHX-UHFFFAOYSA-N CC(C)N1CCC(N(C)C(=O)CC2=CC=C(C3=CC=CC=C3)C=C2)CC1 Chemical compound CC(C)N1CCC(N(C)C(=O)CC2=CC=C(C3=CC=CC=C3)C=C2)CC1 YCTOJFKTSGRHHX-UHFFFAOYSA-N 0.000 description 1
- OABYJYXMOYLUPJ-UHFFFAOYSA-N CC1=C(OCCCC(=O)N(C)C2CCN(C)CC2)C=CC(Cl)=C1 Chemical compound CC1=C(OCCCC(=O)N(C)C2CCN(C)CC2)C=CC(Cl)=C1 OABYJYXMOYLUPJ-UHFFFAOYSA-N 0.000 description 1
- YOHFRYNOHKWGAQ-UHFFFAOYSA-N CC1=CC(SCC(=O)N(C)C2CCN(C)CC2)=C(Cl)C=C1Cl Chemical compound CC1=CC(SCC(=O)N(C)C2CCN(C)CC2)=C(Cl)C=C1Cl YOHFRYNOHKWGAQ-UHFFFAOYSA-N 0.000 description 1
- GMBHJPUOHSMBSA-UHFFFAOYSA-N CC1=CC=C(CC(=O)N(C)C2CCN(C)CC2)C=C1.CC1=CC=C(CC(=O)O)C=C1.CC1=CC=C(CC(=O)OC2=C([N+](=O)[O-])C=C(C(=O)NCP=S)C=C2)C=C1.CNC1CCN(C)CC1.O=C(NCP=S)C1=CC([N+](=O)[O-])=C(O)C=C1 Chemical compound CC1=CC=C(CC(=O)N(C)C2CCN(C)CC2)C=C1.CC1=CC=C(CC(=O)O)C=C1.CC1=CC=C(CC(=O)OC2=C([N+](=O)[O-])C=C(C(=O)NCP=S)C=C2)C=C1.CNC1CCN(C)CC1.O=C(NCP=S)C1=CC([N+](=O)[O-])=C(O)C=C1 GMBHJPUOHSMBSA-UHFFFAOYSA-N 0.000 description 1
- QEOCAUJTBDPZGP-UHFFFAOYSA-N CC1=CC=CC(OCC(=O)N(C)C2CCN(C)CC2)=C1C Chemical compound CC1=CC=CC(OCC(=O)N(C)C2CCN(C)CC2)=C1C QEOCAUJTBDPZGP-UHFFFAOYSA-N 0.000 description 1
- DLKJYWLOFWLCHY-UHFFFAOYSA-N CCCN1CCC(N(C(=O)CC2=CC=C(C3=CC=CC=C3)C=C2)C2CC2)CC1 Chemical compound CCCN1CCC(N(C(=O)CC2=CC=C(C3=CC=CC=C3)C=C2)C2CC2)CC1 DLKJYWLOFWLCHY-UHFFFAOYSA-N 0.000 description 1
- QYLGTVVWYMLFBW-ZHACJKMWSA-N CN1CCC(N(C)C(=O)/C=C/C2=C3C=CC=CC3=CC=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)/C=C/C2=C3C=CC=CC3=CC=C2)CC1 QYLGTVVWYMLFBW-ZHACJKMWSA-N 0.000 description 1
- FNNVLGBFEKNEKG-GQCTYLIASA-N CN1CCC(N(C)C(=O)/C=C/C2=CC=C(F)C(C(F)(F)F)=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)/C=C/C2=CC=C(F)C(C(F)(F)F)=C2)CC1 FNNVLGBFEKNEKG-GQCTYLIASA-N 0.000 description 1
- ACLUFDJWNIZBLB-YFHOEESVSA-N CN1CCC(N(C)C(=O)/C=C\C2=CC=C(N(C)C)C=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)/C=C\C2=CC=C(N(C)C)C=C2)CC1 ACLUFDJWNIZBLB-YFHOEESVSA-N 0.000 description 1
- YNCXJMWBAHTMOZ-GHXNOFRVSA-N CN1CCC(N(C)C(=O)/C=C\C2=CC=C(OCC3=CC=C(F)C=C3)C=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)/C=C\C2=CC=C(OCC3=CC=C(F)C=C3)C=C2)CC1 YNCXJMWBAHTMOZ-GHXNOFRVSA-N 0.000 description 1
- LTKZONHBXQSAHV-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CC2=C(OCC3=CC=CC=C3)C=CC=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CC2=C(OCC3=CC=CC=C3)C=CC=C2)CC1 LTKZONHBXQSAHV-UHFFFAOYSA-N 0.000 description 1
- ILOJFOVJLMSDLR-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CC2=CC=C(C3=CC=CC=C3)C=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CC2=CC=C(C3=CC=CC=C3)C=C2)CC1 ILOJFOVJLMSDLR-UHFFFAOYSA-N 0.000 description 1
- GHQYWOAWKSFMLY-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CC2=CC=C(OC(F)(F)F)C=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CC2=CC=C(OC(F)(F)F)C=C2)CC1 GHQYWOAWKSFMLY-UHFFFAOYSA-N 0.000 description 1
- CXVBZBZXHIYJGX-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CC2=CC=CC(OC(F)(F)F)=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CC2=CC=CC(OC(F)(F)F)=C2)CC1 CXVBZBZXHIYJGX-UHFFFAOYSA-N 0.000 description 1
- RCIOSHGJHVGGMB-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CCC(=O)C2=CC3=C(C=C2)OCCCO3)CC1 Chemical compound CN1CCC(N(C)C(=O)CCC(=O)C2=CC3=C(C=C2)OCCCO3)CC1 RCIOSHGJHVGGMB-UHFFFAOYSA-N 0.000 description 1
- RQPRNPWQUCOJJP-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CCC(=O)C2=CC=C(C3=CC=CC=C3)C=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CCC(=O)C2=CC=C(C3=CC=CC=C3)C=C2)CC1 RQPRNPWQUCOJJP-UHFFFAOYSA-N 0.000 description 1
- IMTATUNFUXBACA-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CCC2=CC3=C(C=C2)OCO3)CC1 Chemical compound CN1CCC(N(C)C(=O)CCC2=CC3=C(C=C2)OCO3)CC1 IMTATUNFUXBACA-UHFFFAOYSA-N 0.000 description 1
- PPWAPQDCOKYKDT-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CCC2=CC=C(Cl)C=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CCC2=CC=C(Cl)C=C2)CC1 PPWAPQDCOKYKDT-UHFFFAOYSA-N 0.000 description 1
- WMQIOZQAYGZJCQ-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CCC2=CC=C(OC(=O)N(C)C)C=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CCC2=CC=C(OC(=O)N(C)C)C=C2)CC1 WMQIOZQAYGZJCQ-UHFFFAOYSA-N 0.000 description 1
- AJJNLYUMBFHQKF-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CCC2=CN=CC=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CCC2=CN=CC=C2)CC1 AJJNLYUMBFHQKF-UHFFFAOYSA-N 0.000 description 1
- QDJQEYKWFUDNAR-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CCCCC2CCCCC2)CC1 Chemical compound CN1CCC(N(C)C(=O)CCCCC2CCCCC2)CC1 QDJQEYKWFUDNAR-UHFFFAOYSA-N 0.000 description 1
- NYZBHRMXYHTDCZ-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CCCOC2=C(Cl)C=C(Cl)C=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CCCOC2=C(Cl)C=C(Cl)C=C2)CC1 NYZBHRMXYHTDCZ-UHFFFAOYSA-N 0.000 description 1
- SZLXJYPKCFFZLO-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CCN2C(=O)OC3=C2C=CC=C3)CC1 Chemical compound CN1CCC(N(C)C(=O)CCN2C(=O)OC3=C2C=CC=C3)CC1 SZLXJYPKCFFZLO-UHFFFAOYSA-N 0.000 description 1
- VWZZJVHYPVNCJU-UHFFFAOYSA-N CN1CCC(N(C)C(=O)COC2=C(Cl)C(Cl)=CC=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)COC2=C(Cl)C(Cl)=CC=C2)CC1 VWZZJVHYPVNCJU-UHFFFAOYSA-N 0.000 description 1
- QYQMDLDXMTYQNA-UHFFFAOYSA-N CN1CCC(N(C)C(=O)COC2=C(Cl)C=CC=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)COC2=C(Cl)C=CC=C2)CC1 QYQMDLDXMTYQNA-UHFFFAOYSA-N 0.000 description 1
- DKPFAKBFXKPJHN-UHFFFAOYSA-N CN1CCC(N(C)C(=O)COC2=C3C=CC=CC3=CC=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)COC2=C3C=CC=CC3=CC=C2)CC1 DKPFAKBFXKPJHN-UHFFFAOYSA-N 0.000 description 1
- MHCWVSDIMXERSO-UHFFFAOYSA-N CN1CCC(N(C)C(=O)COC2=CC=C(F)C=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)COC2=CC=C(F)C=C2)CC1 MHCWVSDIMXERSO-UHFFFAOYSA-N 0.000 description 1
- TYOMCCPBCAUJSP-UHFFFAOYSA-N CN1CCC(N(C)C(=O)COC2=CC=C(OC(F)(F)F)C=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)COC2=CC=C(OC(F)(F)F)C=C2)CC1 TYOMCCPBCAUJSP-UHFFFAOYSA-N 0.000 description 1
- YYIYJXYWLJDLSU-UHFFFAOYSA-N CN1CCC(N(C)C(=O)COC2=CC=C3C=CC=CC3=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)COC2=CC=C3C=CC=CC3=C2)CC1 YYIYJXYWLJDLSU-UHFFFAOYSA-N 0.000 description 1
- YFXHZACWAYRNGQ-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CSC2=C3C(Cl)=CC=CC3=CC=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CSC2=C3C(Cl)=CC=CC3=CC=C2)CC1 YFXHZACWAYRNGQ-UHFFFAOYSA-N 0.000 description 1
- HWFAGDLCMUAYHF-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CSC2=CC=C(F)C=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CSC2=CC=C(F)C=C2)CC1 HWFAGDLCMUAYHF-UHFFFAOYSA-N 0.000 description 1
- OMZXOZVBATXUDY-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CSC2=CC=C(F)C=C2Cl)CC1 Chemical compound CN1CCC(N(C)C(=O)CSC2=CC=C(F)C=C2Cl)CC1 OMZXOZVBATXUDY-UHFFFAOYSA-N 0.000 description 1
- KWUVLKFDXJDBOO-UHFFFAOYSA-N CN1CCC(N(C)C(=O)CSC2=CC=C3C=CC=CC3=C2)CC1 Chemical compound CN1CCC(N(C)C(=O)CSC2=CC=C3C=CC=CC3=C2)CC1 KWUVLKFDXJDBOO-UHFFFAOYSA-N 0.000 description 1
- OBNJFKGDJWPZPQ-HJWRWDBZSA-N COC1=C(/C=C\C(=O)N(C)C2CCN(C)CC2)C=CC=C1 Chemical compound COC1=C(/C=C\C(=O)N(C)C2CCN(C)CC2)C=CC=C1 OBNJFKGDJWPZPQ-HJWRWDBZSA-N 0.000 description 1
- FBKLISPHNYIIGK-UHFFFAOYSA-N COC1=C(CCC(=O)N(C)C2CCN(C)CC2)C=CC=C1 Chemical compound COC1=C(CCC(=O)N(C)C2CCN(C)CC2)C=CC=C1 FBKLISPHNYIIGK-UHFFFAOYSA-N 0.000 description 1
- BCPDTYKGQNSURX-UHFFFAOYSA-N COC1=C(F)C=C(C(=O)CCC(=O)N(C)C2CCN(C)CC2)C=C1 Chemical compound COC1=C(F)C=C(C(=O)CCC(=O)N(C)C2CCN(C)CC2)C=C1 BCPDTYKGQNSURX-UHFFFAOYSA-N 0.000 description 1
- HTLDRXIUIGGJMN-UHFFFAOYSA-N COC1=C(OC)C=C(CCC(=O)N(C)C2CCN(C)CC2)C=C1 Chemical compound COC1=C(OC)C=C(CCC(=O)N(C)C2CCN(C)CC2)C=C1 HTLDRXIUIGGJMN-UHFFFAOYSA-N 0.000 description 1
- CEHOGSHIFATWBB-WAYWQWQTSA-N COC1=CC(/C=C\C(=O)N(C)C2CCN(C)CC2)=CC(OC)=C1 Chemical compound COC1=CC(/C=C\C(=O)N(C)C2CCN(C)CC2)=CC(OC)=C1 CEHOGSHIFATWBB-WAYWQWQTSA-N 0.000 description 1
- ADKXIQWKHKDDAO-BENRWUELSA-N COC1=CC(/C=C\C(=O)N(C)C2CCN(C)CC2)=CC=C1OCC1=CC=CC=C1 Chemical compound COC1=CC(/C=C\C(=O)N(C)C2CCN(C)CC2)=CC=C1OCC1=CC=CC=C1 ADKXIQWKHKDDAO-BENRWUELSA-N 0.000 description 1
- AVKQQEOLTKQARU-UHFFFAOYSA-N COC1=CC(CCC(=O)N(C)C2CCN(C)CC2)=CC(OC)=C1OC Chemical compound COC1=CC(CCC(=O)N(C)C2CCN(C)CC2)=CC(OC)=C1OC AVKQQEOLTKQARU-UHFFFAOYSA-N 0.000 description 1
- FSZSPCPLMRKDDO-VURMDHGXSA-N COC1=CC(OC)=C(/C=C\C(=O)N(C)C2CCN(C)CC2)C=C1 Chemical compound COC1=CC(OC)=C(/C=C\C(=O)N(C)C2CCN(C)CC2)C=C1 FSZSPCPLMRKDDO-VURMDHGXSA-N 0.000 description 1
- ZBWAXGGYQSHUHQ-SOFGYWHQSA-N COC1=CC=C(/C=C/C(=O)N(C)C2CCN(C)CC2)C(Cl)=C1OC Chemical compound COC1=CC=C(/C=C/C(=O)N(C)C2CCN(C)CC2)C(Cl)=C1OC ZBWAXGGYQSHUHQ-SOFGYWHQSA-N 0.000 description 1
- QWXXZTQYSUFNSD-UHFFFAOYSA-N COC1=CC=C(CCC(=O)N(C)C2CCN(C)CC2)C=C1 Chemical compound COC1=CC=C(CCC(=O)N(C)C2CCN(C)CC2)C=C1 QWXXZTQYSUFNSD-UHFFFAOYSA-N 0.000 description 1
- HAIWLSQAGILMGB-UHFFFAOYSA-N COC1=CC=C(CCCC(=O)N(C)C2CCN(C)CC2)C=C1 Chemical compound COC1=CC=C(CCCC(=O)N(C)C2CCN(C)CC2)C=C1 HAIWLSQAGILMGB-UHFFFAOYSA-N 0.000 description 1
- BWQVKVHBRTWVHR-UHFFFAOYSA-N COC1=CC=C(CCCC(=O)N(C)C2CCN(C)CC2)C=C1OC Chemical compound COC1=CC=C(CCCC(=O)N(C)C2CCN(C)CC2)C=C1OC BWQVKVHBRTWVHR-UHFFFAOYSA-N 0.000 description 1
- IFBVWHJHKJXFSA-FPLPWBNLSA-N COC1=CC=CC(/C=C\C(=O)N(C)C2CCN(C)CC2)=C1 Chemical compound COC1=CC=CC(/C=C\C(=O)N(C)C2CCN(C)CC2)=C1 IFBVWHJHKJXFSA-FPLPWBNLSA-N 0.000 description 1
- WBOPGYQJUKQKOZ-HJWRWDBZSA-N COC1=CC=CC(/C=C\C(=O)N(C)C2CCN(C)CC2)=C1OC Chemical compound COC1=CC=CC(/C=C\C(=O)N(C)C2CCN(C)CC2)=C1OC WBOPGYQJUKQKOZ-HJWRWDBZSA-N 0.000 description 1
- UBTJNXQLNCLLGD-UHFFFAOYSA-N COC1=CC=CC(CCC(=O)N(C)C2CCN(C)CC2)=C1 Chemical compound COC1=CC=CC(CCC(=O)N(C)C2CCN(C)CC2)=C1 UBTJNXQLNCLLGD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/245,236 US20030186963A1 (en) | 2001-09-14 | 2002-09-12 | Substituted piperidines |
US10/891,553 US7767695B2 (en) | 2001-09-14 | 2004-07-15 | Substituted piperidines |
US12/779,435 US20100222386A1 (en) | 2001-09-14 | 2010-05-13 | Substituted piperidines |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200101344 | 2001-09-14 | ||
DKPA200101344 | 2001-09-14 | ||
US32300401P | 2001-09-18 | 2001-09-18 | |
US10/245,236 US20030186963A1 (en) | 2001-09-14 | 2002-09-12 | Substituted piperidines |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/891,553 Continuation US7767695B2 (en) | 2001-09-14 | 2004-07-15 | Substituted piperidines |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030186963A1 true US20030186963A1 (en) | 2003-10-02 |
Family
ID=28457454
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/245,236 Abandoned US20030186963A1 (en) | 2001-09-14 | 2002-09-12 | Substituted piperidines |
US10/891,553 Expired - Fee Related US7767695B2 (en) | 2001-09-14 | 2004-07-15 | Substituted piperidines |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/891,553 Expired - Fee Related US7767695B2 (en) | 2001-09-14 | 2004-07-15 | Substituted piperidines |
Country Status (1)
Country | Link |
---|---|
US (2) | US20030186963A1 (US20030186963A1-20031002-C00035.png) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7169926B1 (en) | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US20070142369A1 (en) * | 2005-12-21 | 2007-06-21 | Margaret Van Heek | Combination of an H3 antagonist/inverse agonist and an appetite suppressant |
WO2008127727A1 (en) * | 2007-04-13 | 2008-10-23 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
US20080287476A1 (en) * | 2007-03-13 | 2008-11-20 | Takeda Pharmaceutical Company Limited | Administration of dipeptidyl peptidase inhibitors |
US20090149510A1 (en) * | 2007-07-06 | 2009-06-11 | Hangauer Jr David G | Compositions and methods for modulating a kinase cascade |
US7678909B1 (en) | 2003-08-13 | 2010-03-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7687638B2 (en) | 2004-06-04 | 2010-03-30 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
US7687625B2 (en) | 2003-03-25 | 2010-03-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7723344B2 (en) | 2003-08-13 | 2010-05-25 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
US7732446B1 (en) | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7781584B2 (en) | 2004-03-15 | 2010-08-24 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7790734B2 (en) | 2003-09-08 | 2010-09-07 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7825242B2 (en) | 2004-07-16 | 2010-11-02 | Takeda Pharmaceutical Company Limted | Dipeptidyl peptidase inhibitors |
US7872124B2 (en) | 2004-12-21 | 2011-01-18 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7960384B2 (en) | 2006-03-28 | 2011-06-14 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8084605B2 (en) | 2006-11-29 | 2011-12-27 | Kelly Ron C | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
US8222411B2 (en) | 2005-09-16 | 2012-07-17 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
US8906901B2 (en) | 2005-09-14 | 2014-12-09 | Takeda Pharmaceutical Company Limited | Administration of dipeptidyl peptidase inhibitors |
WO2016198691A1 (en) * | 2015-06-11 | 2016-12-15 | Basilea Pharmaceutica Ag | Efflux-pump inhibitors and therapeutic uses thereof |
US9926273B2 (en) | 2012-08-30 | 2018-03-27 | Athenex, Inc. | Composition and methods for modulating a kinase cascade |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3337551A (en) * | 1965-01-08 | 1967-08-22 | Dow Chemical Co | Heterocyclic amides of 2, 6-dioxo-4-piperidineacetic acid |
US3577440A (en) * | 1968-12-23 | 1971-05-04 | Robins Co Inc A H | 1-substituted-3-amido-pyrrolidines |
IN148482B (US20030186963A1-20031002-C00035.png) | 1977-06-03 | 1981-03-07 | Pfizer | |
WO1983003410A1 (en) | 1982-04-02 | 1983-10-13 | Takeda Chemical Industries Ltd | Isoindolin derivatives |
WO1984003089A1 (en) | 1983-02-05 | 1984-08-16 | Takeda Chemical Industries Ltd | Condensed pyrrolinone derivatives |
WO1984001576A1 (en) | 1982-10-07 | 1984-04-26 | Takeda Chemical Industries Ltd | Fused pyrrolinone derivatives |
US4943573A (en) * | 1989-11-01 | 1990-07-24 | Bristol-Myers Squibb Company | Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility |
TW593317B (en) | 1993-06-21 | 2004-06-21 | Janssen Pharmaceutica Nv | Positive cardiac inotropic and lusitropic pyrroloquinolinone derivatives |
AU5014496A (en) | 1995-03-23 | 1996-10-08 | Japan Tobacco Inc. | Diphenylmethyl-azetidinone compounds and elastase inhibitor |
SI0863897T1 (en) | 1995-11-09 | 1999-10-31 | Sanofi - Synthelabo | 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one derivatives for use as 5-ht4- or h3-receptor ligands |
DE19618999A1 (de) | 1996-05-10 | 1997-11-13 | Klinge Co Chem Pharm Fab | Neue Benzothiazolinone |
DE19618970A1 (de) | 1996-05-10 | 1997-11-13 | Klinge Co Chem Pharm Fab | Neue Thiazolopyridine |
GB9803536D0 (en) | 1998-02-19 | 1998-04-15 | Black James Foundation | Histamine H,receptor ligands |
DE69929877T2 (de) | 1998-03-20 | 2006-08-10 | Daiichi Asubio Pharma Co., Ltd. | BENZOCHINONDERIVATE ENTHALTENDE HEMMER VON NF-kB |
EP0978512A1 (en) | 1998-07-29 | 2000-02-09 | Societe Civile Bioprojet | Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications |
KR100676109B1 (ko) * | 1998-10-16 | 2007-02-01 | 다이이치 아스비오파마 가부시키가이샤 | 신경보호제로서의 아미노페녹시아세트산 유도체 |
HUP0104841A3 (en) | 1999-09-17 | 2002-07-29 | Daiichi Suntory Pharma Co Ltd | Medicaments containing benzoquinone- or condensed pyrimidine derivatives as active ingredient for treating of myocarditis, dilated cardiomyopathy and cardiac insufficiency |
FR2802206B1 (fr) | 1999-12-14 | 2005-04-22 | Sod Conseils Rech Applic | Derives de 4-aminopiperidine et leur utilisation en tant que medicament |
ES2291308T3 (es) | 2000-04-13 | 2008-03-01 | Asubio Pharma Co., Ltd. | Derivados de aminofenoxiacetamida y composicion farmaceutica que contiene los mismos. |
US6673829B2 (en) * | 2001-09-14 | 2004-01-06 | Novo Nordisk A/S | Aminoazetidine,-pyrrolidine and -piperidine derivatives |
-
2002
- 2002-09-12 US US10/245,236 patent/US20030186963A1/en not_active Abandoned
-
2004
- 2004-07-15 US US10/891,553 patent/US7767695B2/en not_active Expired - Fee Related
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7687625B2 (en) | 2003-03-25 | 2010-03-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7678909B1 (en) | 2003-08-13 | 2010-03-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7169926B1 (en) | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7790736B2 (en) | 2003-08-13 | 2010-09-07 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7723344B2 (en) | 2003-08-13 | 2010-05-25 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
US7790734B2 (en) | 2003-09-08 | 2010-09-07 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7732446B1 (en) | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8173663B2 (en) | 2004-03-15 | 2012-05-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8188275B2 (en) | 2004-03-15 | 2012-05-29 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7781584B2 (en) | 2004-03-15 | 2010-08-24 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8288539B2 (en) | 2004-03-15 | 2012-10-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8329900B2 (en) | 2004-03-15 | 2012-12-11 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7807689B2 (en) | 2004-03-15 | 2010-10-05 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7906523B2 (en) | 2004-03-15 | 2011-03-15 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7687638B2 (en) | 2004-06-04 | 2010-03-30 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
US7825242B2 (en) | 2004-07-16 | 2010-11-02 | Takeda Pharmaceutical Company Limted | Dipeptidyl peptidase inhibitors |
US7872124B2 (en) | 2004-12-21 | 2011-01-18 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8906901B2 (en) | 2005-09-14 | 2014-12-09 | Takeda Pharmaceutical Company Limited | Administration of dipeptidyl peptidase inhibitors |
US8222411B2 (en) | 2005-09-16 | 2012-07-17 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US20070142369A1 (en) * | 2005-12-21 | 2007-06-21 | Margaret Van Heek | Combination of an H3 antagonist/inverse agonist and an appetite suppressant |
US7960384B2 (en) | 2006-03-28 | 2011-06-14 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
US8084605B2 (en) | 2006-11-29 | 2011-12-27 | Kelly Ron C | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
US20080287476A1 (en) * | 2007-03-13 | 2008-11-20 | Takeda Pharmaceutical Company Limited | Administration of dipeptidyl peptidase inhibitors |
US20100256147A1 (en) * | 2007-04-13 | 2010-10-07 | Hangauer Jr David G | Biaryl acetamide derivatives as modulators of the kinase cascade for the treatment of hearing loss, osteoporosis and cell proliferation disorders |
WO2008127727A1 (en) * | 2007-04-13 | 2008-10-23 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
US8124605B2 (en) | 2007-07-06 | 2012-02-28 | Kinex Pharmaceuticals, Llc | Compositions and methods for modulating a kinase cascade |
US20090149510A1 (en) * | 2007-07-06 | 2009-06-11 | Hangauer Jr David G | Compositions and methods for modulating a kinase cascade |
US9926273B2 (en) | 2012-08-30 | 2018-03-27 | Athenex, Inc. | Composition and methods for modulating a kinase cascade |
US10106505B2 (en) | 2012-08-30 | 2018-10-23 | Athenex, Inc. | Composition and methods for modulating a kinase cascade |
WO2016198691A1 (en) * | 2015-06-11 | 2016-12-15 | Basilea Pharmaceutica Ag | Efflux-pump inhibitors and therapeutic uses thereof |
US10464896B2 (en) | 2015-06-11 | 2019-11-05 | Basilea Pharmaceutica International AG | Efflux-pump inhibitors and therapeutic uses thereof |
Also Published As
Publication number | Publication date |
---|---|
US7767695B2 (en) | 2010-08-03 |
US20040248938A1 (en) | 2004-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1434765B1 (en) | Substituted piperidines with selective binding to histamine h3-receptor | |
US7767695B2 (en) | Substituted piperidines | |
US6673829B2 (en) | Aminoazetidine,-pyrrolidine and -piperidine derivatives | |
US7064135B2 (en) | Substituted piperidines | |
EP1430027B1 (en) | Novel aminoazetidine, -pyrrolidine and -piperidine derivatives | |
US7294626B2 (en) | Piperazines | |
US7799924B2 (en) | Substituted homopiperidine, piperidine or pyrrolidine derivatives | |
EP1474419B1 (en) | Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes | |
US7101898B2 (en) | Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes | |
JP5694661B2 (ja) | 3−(1,3−ベンゾジオキソル−5−イル)−6−(4−シクロプロピルピペラジン−1−イル)−ピリダジンと、その塩と、その溶媒和物と、そのヒスタミンh3受容体アンタゴニストとしての利用法 | |
US7208497B2 (en) | Substituted piperazines and diazepanes | |
EP2243776A1 (en) | Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor | |
AU2003203143A1 (en) | Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes | |
US20110009420A1 (en) | Histamine H3 Receptor Ligands | |
AU2011236055A1 (en) | 3- (1, 3-benzodioxol-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine H3 receptor antagonist |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NOVO NORDISK A/S A, DENMARK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DORWALD, FLORENCIO ZARAGOZA;REEL/FRAME:013559/0489 Effective date: 20021123 Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DORWALD, FLORENCIO ZARAGOZA;REEL/FRAME:013559/0489 Effective date: 20021123 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: NOVO NORDISK A/S, DENMARK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOEHRINGER INGELHEIM INTERNATIONAL, GMBH;REEL/FRAME:020541/0001 Effective date: 20080207 |